Pfizer's suffering from generics, but 'innovation for growth'—not big M&A—is still the mantra - FiercePharma

Recent Post

  1. Pfizer's suffering from generics, but 'innovation for growth'—not big M&A—is still the mantra  FiercePharma
  2. Pfizer's earnings outlook disappoints after Viagra loses patent protection and Lyrica faces same fate  CNBC
  3. Pfizer quarterly profit in line, touts pipeline of future products  Yahoo Finance
  4. Pfizer Tops Q4 Earnings But Guides for Weaker 2019 as Lyrica Exclusivity Ends  TheStreet.com
  5. Pfizer's Outlook Disappoints as Drugmaker Focuses on Pipeline  Bloomberg
  6. View full coverage on Google News


from Business - Latest - Google News http://bit.ly/2G9KLRV

Post a Comment

Emoticon
:) :)) ;(( :-) =)) ;( ;-( :d :-d @-) :p :o :>) (o) [-( :-? (p) :-s (m) 8-) :-t :-b b-( :-# =p~ $-) (b) (f) x-) (k) (h) (c) cheer
Click to see the code!
To insert emoticon you must added at least one space before the code.

MKRdezign

Contact Form

Name

Email *

Message *

Powered by Blogger.
Javascript DisablePlease Enable Javascript To See All Widget